Atlas Trials

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Clinical trial NCT07253129 · RECRUITING

Trial details

NCT number
NCT07253129
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
Peripheral T Cell Lymphoma
Start date
2025-12-31
Primary completion
2029-05-30
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.